Stress oxydatif And NotWEI SONG
List of bibliographic references
Number of relevant bibliographic references: 44.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000019 | Karima Maaroufi [France, Tunisie] ; Laurence Had-Aissouni [France] ; Christophe Melon [France] ; Mohsen Sakly [Tunisie] ; Hafedh Abdelmelek [Tunisie] ; Bruno Poucet [France] ; Etienne Save [France] | Spatial learning, monoamines and oxidative stress in rats exposed to 900 MHz electromagnetic field in combination with iron overload |
| 000031 | C. A. Gautier [France] ; O. Corti [France] ; A. Brice [France] | Mitochondrial dysfunctions in Parkinson's disease |
| 000275 | J.-C. Stoclet [France] ; V. Schini-Kerth [France] | Flavonïdes alimentaires et santé humaine |
| 000309 | G. Watfa [France] ; C. Dragonas [Allemagne] ; T. Brosche [Allemagne] ; R. Dittrich [Allemagne] ; C. C. Sieber [Allemagne] ; C. Alecu [France] ; A. Benetos [France] ; R. Nzietchueng [France] | STUDY OF TELOMERE LENGTH AND DIFFERENT MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH PARKINSON'S DISEASE |
| 000680 | Pierre Cesaro [France] | Neuroprotection et maladie de Parkinson |
| 000781 | Daniel Alvarez-Fischer [Allemagne] ; Carmen Henze [Allemagne] ; Corinna Strenzke [Allemagne] ; Jan Westrich [Allemagne] ; Boris Ferger [Allemagne] ; Günter U. Höglinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Andreas Hartmann [Allemagne, France] | Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice |
| 000879 | Laila Amazzal [France] ; Agnès Lapotre [France] ; Frédéric Quignon [France] ; Denyse Bagrel [France] | Mangiferin protects against 1 -methyl -4 -phenylpyridinium toxicity mediated by oxidative stress in N2A cells |
| 000926 | A. Favier [France] | Stress oxydant stress oxydant et pathologies humaines |
| 000960 | P. Rustin [France] | Ataxie de Friedreich : dix ans de recherches |
| 000988 | Julien Finaud [France] ; Gérard Lac [France] ; Edith Filaire [France] | Oxidative stress : Relationship with exercise and training |
| 000A89 | Victoria J. Findlay [États-Unis] ; Haim Tapiero [France] ; Danyelle M. Townsend [États-Unis] | Sulfiredoxin : a potential therapeutic agent? : Antioxidants in the Prevention of Human Diseases |
| 000C26 | J. Emerit [France] ; M. Edeas [France] ; F. Bricaire [France] | Neurodegenerative diseases and oxidative stress |
| 000C92 | A. Destee [France] | Neuroprotection et syndromes parkinsoniens neurodégénératifs |
| 000D58 | Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease |
| 000E26 | Jean-Claude Desport [France] ; Philippe Couratier [France] | Stress oxydant et maladies neurodégénératives |
| 000E87 | Jean Dessolin [France] ; Marie Schuler [France] ; Alice Quinart [France] ; Francesca De Giorgi [France] ; Leon Ghosez [France] ; Francois Ichas [France] | Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases? |
| 000F14 | Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France] | Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine |
| 000F27 | Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Stéphane Hunot [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] | Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease |
| 000F36 | K. L. Double [Australie] ; D. Ben-Shachar [Israël] ; M. B. H. Youdim [Israël] ; L. Zecca [Italie] ; P. Riederer [Allemagne] ; M. Gerlach [Allemagne] | Influence of neuromelanin on oxidative pathways within the human substantia nigra |
| 000F64 | Michel Dib [France] ; Catherine Garrel [France] ; Alain Favier [France] ; Valérie Robin [France] ; Claude Desnuelle [France] | Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? |
| 000F98 | M. P. Lehucher-Michel [France] ; J. F. Lesgards [France] ; O. Delubac [France] ; P. Stocker [France] ; P. Durand [France] ; M. Prost [France] | Stress oxydant et pathologies humaines: Bilan et perspectives préventives |
| 001049 | Laurent Groc [États-Unis, France] ; Laurent Bezin [États-Unis, France] ; Jane A. Foster [États-Unis] ; HAO JIANG [États-Unis] ; Tangella S. Jackson [États-Unis] ; Dinah Weissmann [France] ; Robert A. Levine [États-Unis] | Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development |
| 001051 | Carine Fillebeen [France] ; Marie-Magdeleine Ruchoux [France] ; Valérie Mitchell [France] ; Sylvie Vincent [France] ; Monique Benaïssa [France] ; Annick Pierce [France] | Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor a or 1-methyl-4-phenylpyridinium treatment |
| 001095 | David Blum [Belgique, France] ; Sakina Torch [France] ; Marie-France Nissou [France] ; Jean-Marc Verna [France] | 6-hydroxydopamine-induced nuclear factor-kappab activation in PC12 cells |
| 001129 | M. Ruberg [France] | Maladie de Parkinson: Vers un mécanisme de mort neuronale |
| 001158 | F. De La Fourniere [France] ; B. Placines [France] ; M. Dehorne [France] ; D. Albert [France] ; J. F. Lagabrielle [France] ; P. Grandet ; J. F. Dartigues [France] | Diminution de l'activité de la glutathion peroxydase plaquettaire chez les parkinsoniens âgés |
| 001218 | D. Blum [Belgique, France] ; S. Torch [France] ; M.-F. Nissou [France] ; A.-L. Benabid [France] ; J.-M. Verna [France] | Extracellular toxicity of 6-hydroxydopamine on PC12 cells |
| 001257 | La lactoferrine cérébrale : Origines et mécanismes d'accumulation au cours des maladies neurodégénératives | |
| 001268 | J. Y. Follezou [France] ; J. Emerit [France] ; F. Bricaire [France] | Maladies neurodégénératives: rôle des espèces activées de l'oxygène et de l'apoptose |
| 001313 | A. M. Bonnet [France] ; J. L. Houeto [France] | Pathophysiology of Parkinson's disease |
| 001315 | M. Merad-Saïdoune [France] ; E. Boitier [France] ; A. Nicole [France] ; C. Marsac [France] ; J. C. Martinou [Suisse] ; B. Sola [France] ; P.-M. Sinet [France] ; I. Ceballos-Picot [France] | Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion |
| 001323 | R. S. El-Bacha [France] ; P. Netter [France] ; A. Minn [France] | Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells : protection by bovine serum albumin and formation of apomorphine-protein conjugates |
| 001328 | C. Fillebeen [France] ; V. Mitchell [France] ; D. Dexter [Royaume-Uni] ; M. Benaissa [France] ; J.-C. Beauvillain [France] ; G. Spik [France] ; A. Pierce [France] | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment |
| 001402 | A. Nieoullon [France] | Bases cellulaires des processus neurodégénératifs |
| 001436 | M. Merad-Boudia [France] ; A. Nicole [France] ; D. Santiard-Baron [France] ; C. Saille [France] ; I. Ceballos-Picot [France] | Mitochondrial impairment as an early event in th process of apoptosis induced by glutathione depletion in neuronal cells : Relevance to Parkinson's disease |
| 001453 | P. Morel [France] ; C. Tallineau [France] ; R. Pontcharraud [France] ; A. Piriou [France] ; F. Huguet [France] | Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes |
| 001458 | A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France] | Direct evidence for glutathione as mediator of apoptosis in neuronal cells : Dossier "Apoptosis Part II" |
| 001508 | P. Damier [France] | Lésions neurochimiques et mécanismes de la mort neuronale dans la maladie de Parkinson : Maladie de Parkinson |
| 001515 | M. Ruberg [France] ; V. France-Lanord [France] ; B. Brugg [France] ; N. Lambeng [France] ; P. P. Michel [France] ; P. Anglade [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] ; E. Hirsch [France] ; Yves Agid [France] | La mort neuronale par apoptose dans la maladie de Parkinson |
| 001547 | B. A. Faucheux [France] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease |
| 001606 | Vulnérabilité différentielle des neurones dopaminergiques dans la maladie de parkinson: un rôle du stress oxydatif et de l'environnement glial ? | |
| 001618 | P. Morel [France] | Les perspectives thérapeutiques de la maladie de Parkinson |
| 001667 | B. Leveugle [États-Unis] ; B. A. Faucheux [France] ; C. Bouras ; N. Nillesse [France] ; G. Spik [France] ; E. C. Hirsch [France] ; Y. Agig [France] ; P. R. Hof [États-Unis] | Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases |
| 001750 | Enzymes de protection contre les radicaux libres dans le système nerveux central de l'homme ― avec une référence particulière pour le mécanisme de la mort des neurones dopaminergiques dans la maladie de Parkinson |
| This area was generated with Dilib version V0.6.29. |  |